Daniel Joseph Mc Carthy Evolent Health, Inc. (EVH) insider trading activity

Daniel Joseph Mc Carthy is PRESIDENT of Evolent Health, Inc.. Currently has a direct ownership of 389,004 shares of EVH, which is worth approximately $3.54 Million. The most recent transaction as insider was on Mar 06, 2025, when has been sold 11,040 shares (Class A Common Stock) at a price of $9.01 per share, resulting in proceeds of $99,470. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 389K

106.54% 3M change

78.48% 12M change

Total Value Held $3.54 Million

Daniel Joseph McCarthy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2025	BUY Open market or private purchase	$99,470 $9.01 p/Share	11,040 Added 2.76%	389,004 Class A Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$346,423 $8.77 p/Share	39,501 Reduced 9.46%	377,964 Class A Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	-	244,268 Added 36.91%	417,465 Class A Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$136,135 $8.99 p/Share	15,143 Reduced 8.04%	173,197 Class A Common Stock
Aug 23 2024	SELL Open market or private sale	$340,242 $32.5 p/Share	10,469 Reduced 5.27%	188,340 Class A Common Stock
Aug 22 2024	SELL Open market or private sale	$746,329 $31.5 p/Share	23,693 Reduced 10.65%	198,809 Class A Common Stock
Aug 22 2024	BUY Exercise of conversion of derivative security	$112,612 $24.75 p/Share	4,550 Added 2.0%	222,502 Class A Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$194,003 $34.41 p/Share	5,638 Reduced 2.52%	217,952 Class A Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$454,556 $34.41 p/Share	13,210 Reduced 5.58%	223,590 Class A Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	19,398 Added 7.57%	236,800 Class A Common Stock
Feb 22 2024	SELL Payment of exercise price or tax liability	$278,475 $33.03 p/Share	8,431 Reduced 3.73%	217,402 Class A Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	27,500 Added 10.86%	225,833 Class A Common Stock
Nov 15 2023	SELL Open market or private sale	$330,000 $30.0 p/Share	11,000 Reduced 5.25%	198,333 Class A Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$31,950 $10.65 p/Share	3,000 Added 1.47%	201,333 Class A Common Stock
Jun 12 2023	SELL Open market or private sale	$31,440 $31.44 p/Share	1,000 Reduced 0.48%	206,333 Class A Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$164,748 $35.15 p/Share	4,687 Reduced 2.21%	207,333 Class A Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$86,633 $35.26 p/Share	2,457 Reduced 1.15%	212,020 Class A Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	27,557 Added 11.39%	214,477 Class A Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$237,584 $28.08 p/Share	8,461 Reduced 4.33%	186,920 Class A Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	-	27,500 Added 12.34%	195,381 Class A Common Stock

DJM

Daniel Joseph Mc Carthy

PRESIDENT

Arlington, VA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVH shares.

Notify only if

Value

Insider Trading

Get notified when an Evolent Health, Inc. insider buys or sells EVH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Evolent Health, Inc.

Track Activities on EVH

Account